Chlamydia pneumoniae (TWAR Strain) Protein

Specifications

Product Data
Description	Chlamydia pneumoniae (TWAR Strain) protein, 1 ml
Protein Source	HL
Concentration	lot specific
Purity	Optimally infected Cells are harvested and centrifuged to pellet cellular debris
Buffer	Presentation State: Lysate State: Liquid lysate Buffer System: SPG buffer without preservatives
Preparation	Liquid lysate
Applications	Suitable for use in EIA and Western Blot. Each laboratory should determine an optimum working titer for use in its particular application.
Protein Description	Chlamydia Pneumoniae (TWAR Strain).  Chlamydia pneumoniae (TWAR Strain) is a common respiratory pathogen, the causal agent of a variety of mild to moderate respiratory illnesses. Inactivation: Inactivated by gamma irradiation. The effectiveness of inactivation is tested by inclusion forming assay. If no inclusions are observed, the antigen is considered inactivated. Result: 0 IFU/mL.
Note	Caution: No test guarantees a product to be non-infectious. All materials should be handled as if potentially infectious. Generally accepted laboratory practices appropriate for infectious materials should be employed when handling this product.
Storage	Upon receipt, store (in aliquots) at -20°C to -80°C. Avoid repeated freezing and thawing.
Stability	Shelf life: one year from despatch.
Reference Data
Summary	Chlamydia Pneumoniae is a ubiquitous pathogen that causes acute respiratory disease. The spectrum of C. Pneumoniae infection has been extended to atherosclerosis and its clinical manifestations. A high proportion of adults from different countries are positive for antibodies to C. Pneumoniae, implying a high prevalence of these infections. The chlamydia are obligate intracellular bacteria characterized by a unique growth cycle.

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.